Anno2015
AutoriMilanese M.; Bonifacino T.; Fedele E.; Rebosio C.; Cattaneo L.; Benfenati F.; Usai C.; Bonanno G.
AbstractThe impact of synaptic vesicle endo-exocytosis on the trafficking of nerve terminal heterotransporters was studied by monitoring membrane expression and function of the GABA transporter-1 (GAT-1) and of type-1/2 glycine (Gly) transporters (GlyT-1/2) at spinal cord glutamatergic synaptic boutons. Experiments were performed by inducing exocytosis in wild-type (WT) mice, in amphiphysin-1 knockout (Amph-1 KO) mice, which show impaired endocytosis, or in mice expressing high copy number of mutant human SOD1 with a Gly93Ala substitution (SOD1(G93A)), a model of human amyotrophic lateral sclerosis showing constitutively excessive Glu exocytosis. Exposure of spinal cord synaptosomes from WT mice to a 35 mM KCl pulse increased the expression of GAT-1 at glutamatergic synaptosomal membranes and enhanced the GAT-1 heterotransporter-induced [H-3]D-aspartate ([H-3]D-Asp) release. Similar results were obtained in the case of GlyT-1/2 heterotransporters. Preventing depolarization-induced exocytosis normalized the excessive GAT-1 and GlyT-1/2 heterotransporter-induced [H-3]D-Asp release in WT mice. Impaired endocytosis in Amph-1 KO mice increased GAT-1 membrane expression and [H-3]GABA uptake in spinal cord synaptosomes. Also the GAT-1 heterotransporter-evoked release of [H-3] D-Asp was augmented in Amph-I KO mice. The constitutively excessive Glu exocytosis in SOD1(G93A) mice resulted in augmented GAT-1 expression at glutamatergic synaptosomal membranes and GAT-1 or GlyT-1/2 heterotransporter-mediated [H-3]D-Asp release. Thus, endo-exocytosis regulates the trafficking of GAT-1 and GlyT-1/2 heterotransporters sited at spinal cord glutamatergic nerve terminals. As a consequence, it can be hypothesized that the excessive GAT-1 and GlyT-1/2 heterotransporter-mediated Glu release, in the spinal cord of SOD1(G93A) mice, is due to the heterotransporter over-expression at the nerve terminal membrane, promoted by the excessive Glu exocytosis.
RivistaNeurobiology Of Disease
ISSN0969-9961
Impact factor0
Volume74
Pagina inizio314
Pagina fine324
Autori IBFCesare USAI
Linee di Ricerca IBFMD.P01.001.001
Sedi IBFIBF.GE